<DOC>
	<DOCNO>NCT00409500</DOCNO>
	<brief_summary>This study evaluate safety , tolerability pharmacokinetics individual oral dos AQW051 Japanese healthy male subject , also evaluate effect food pharmacokinetics AQW051 .</brief_summary>
	<brief_title>Effect Food Pharmacokinetics AQW051 Japanese Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Japanese healthy male subject age 20 45 year age , good health At screen baseline , subject must good health determine past medical history , physical examination , electrocardiogram , laboratory test urinalysis . Body mass index within range 17 25 kg/m2 weigh least 50 kg Smokers ( use tobacco product previous 3 month ) . Urine cotinine level measure screening subject . Smokers define subject report tobacco use urine cotinine ‘ high ’ level check NicCheck® I . Use prescription drug within 4 week prior dose , overthecounter medication ( vitamin , herbal supplement , dietary supplement ) within 2 week prior dose . Acetaminophen acceptable . Participation clinical investigation within 4 month prior study start . Donation loss 400 mL blood within 3 month ; donation loss 200 mL blood within 1 month ; donation component blood within 2 week prior study start . Subjects consider unsuitable participation study within 2 week prior dose . A past medical history clinically significant abnormality detect electrocardiogram ( ECG ) examination evident family history ( grandparent , parent sibling ) ECG abnormality ( i.e . prolonged QTinterval syndrome ) . History fainting , hypotension standing , arrhythmia . History acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . History clinically significant drug allergy , history presence atopic allergy ( asthma , urticaria , eczematous dermatitis ) unless inactive seasonal allergy , history food allergy . A known hypersensitivity study drug drug similar study drug . Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug may jeopardize subject case participation study . History immunodeficiency disease , include positive HIV test result . A positive Hepatitis B surface antigen ( HBsAg ) , Hepatitis C Syphilis test result . History drug alcohol abuse within 12 month prior study participation evidence abuse indicate laboratory assay conduct screening . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Safety , tolerability , pharmacokinetics , AQW051 , food , Japanese , healthy male subject</keyword>
	<keyword>Healthy volunteer study</keyword>
</DOC>